PFAS are a sprawling family of thousands of synthetic compounds prized for their resistance to water, grease, and heat. Since the mid-twentieth century they have been incorporated into nonstick cookware, food packaging, stain-resistant carpets and clothing, firefighting foams, and countless industrial processes. Their defining chemical feature, a backbone of carbon atoms sheathed in fluorine, makes them extraordinarily stable, which is precisely why they accumulate in soil, water, wildlife, and people. Two of the most studied members of the family, perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS), have been phased out of production in the United States but remain detectable in the blood of nearly all Americans, a testament to their persistence and to continued exposure through imported goods, contaminated water, and legacy contamination.

Children are a population of particular concern. Relative to their body weight, they eat, drink, and breathe more than adults, and their developing organs and immune, endocrine, and nervous systems are more vulnerable to disruption. Prior research has linked elevated childhood PFAS exposure to reduced vaccine antibody responses, altered lipid profiles, changes in kidney function, and possible effects on growth and neurodevelopment. Yet most exposure studies have drawn on broad national samples that average away the differences between communities, leaving minority and immigrant populations underrepresented. The new Northern Virginia study was designed to close that gap, focusing specifically on Hispanic children in a region where suburban sprawl, industrial legacy sites, and busy transportation corridors coexist with rapidly changing demographics.

The research team recruited families from the Northern Virginia community and measured concentrations of multiple PFAS compounds in the children’s blood, pairing those biomarkers with detailed questionnaires about diet, food sourcing, household characteristics, and social and economic factors. This combination of exposure biomonitoring and rich behavioral data allowed the investigators to move beyond simply documenting that children carry PFAS in their blood and toward identifying which features of daily life push exposures higher or keep them lower. Such information is critical for designing interventions that families and public health agencies can actually act upon, rather than issuing blanket warnings that offer little practical guidance.

Among the dietary findings, certain food patterns stood out as meaningful contributors to exposure. Diets that included more frequently consumed prepared and restaurant foods, which often involve contact with grease-resistant packaging and processing equipment, were associated with higher levels of some PFAS compounds in the children’s blood. Seafood consumption, long recognized in the exposure literature as a route through which PFAS enter the human body because these chemicals bioaccumulate in aquatic food webs, also emerged as a relevant predictor. At the same time, the study underscored that no single food explains exposure; rather, it is the cumulative pattern of dietary choices, filtered through availability, affordability, and cultural preference, that shapes the chemical signature found in a child’s serum.

The social dimension of the findings is arguably the most consequential. The researchers report that indicators of social position, including household economic circumstances, parental education, and the length of time families had lived in the United States, were intertwined with exposure patterns. Families navigating the constraints of lower incomes may rely more heavily on packaged and convenience foods, may live in housing closer to potential contamination sources, or may have fewer options when it comes to choosing water supplies and food retailers. Recent immigrants may encounter different food environments than those they left behind, and acculturation can shift diets in ways that alter exposure profiles. The study’s authors emphasize that these are not simply lifestyle variables; they are structural conditions that determine which choices are realistically available to a family on a given evening.

This framing matters because it reframes PFAS exposure not as a matter of individual responsibility but as an environmental equity issue. If the chemicals that resist breakdown in the body are also more likely to accumulate in the bodies of children from socially disadvantaged households, then the burden of a largely invisible industrial legacy falls unevenly on communities with the fewest resources to detect or avoid it. Hispanic children in the United States represent a large and growing population, and studies like this one provide the community-specific evidence base that has historically been missing from regulatory deliberations, which have often relied on data from predominantly white, higher-income cohorts.

The technical approach of the study reflects the current state of the art in exposure science. Serum PFAS concentrations were quantified using liquid chromatography coupled with tandem mass spectrometry, the gold-standard analytical method capable of detecting these compounds at the parts-per-billion and parts-per-trillion levels found in human blood. Statistical modeling was then used to estimate the independent contribution of each dietary and social predictor while adjusting for the others, a necessary step because diet, income, and acculturation are deeply correlated in real households. The researchers also had to contend with the changing composition of PFAS exposures themselves: as legacy compounds like PFOA and PFOS decline following their phase-out, replacement chemistries and less-studied congeners are becoming proportionally more important, complicating both measurement and interpretation.

The implications of the work extend in several directions at once. For regulators, the results strengthen the case for reducing PFAS at the source, in food-contact materials and water systems, because expecting families to navigate a contaminated food supply is neither fair nor effective. The recent designation of PFOA and PFOS as hazardous substances under federal superfund law, along with the first national drinking water standards for several PFAS compounds, signals a policy environment that is finally moving, and community-specific exposure research helps ensure that these interventions reach the populations that need them most. For clinicians and public health practitioners, the study suggests that dietary counseling aimed at reducing exposure should be culturally tailored and sensitive to economic realities, rather than translated wholesale from recommendations developed for other populations.

For the families of Northern Virginia, and for Hispanic communities across the country, the study offers both a warning and a measure of agency. The warning is that the forever chemicals are not a distant problem confined to contaminated military bases or industrial towns; they travel through grocery carts, takeout containers, and tap water into the bloodstream of nearly every child. The agency lies in the demonstration that exposure is patterned and therefore predictable, and that what can be predicted can, in principle, be prevented. As the researchers and their community partners continue to follow this cohort, the hope is that the data will translate into practical protections, from cleaner food packaging to targeted health communication, so that the next generation of children in this rapidly changing region carries a lighter chemical inheritance than the last.

Subject of Research: Dietary and social predictors of PFAS exposure among Hispanic children in Northern Virginia

Article Title: Dietary and social predictors of PFAS exposure in Hispanic children from Northern Virginia

Article References: Dietary and social predictors of PFAS exposure in Hispanic children from Northern Virginia. (n.d.). https://doi.org/10.1038/s41370-026-00975-3

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00975-3

Keywords: PFAS, forever chemicals, Hispanic children, Northern Virginia, exposure science, biomonitoring, dietary exposure, environmental justice, PFOA, PFOS, children's health, food packaging

VOCs matter for public health for several reasons. Some members of the family, such as benzene, formaldehyde, and 1,3-butadiene, are recognized carcinogens or respiratory irritants, while others participate in atmospheric chemistry that generates ground-level ozone and secondary organic aerosol, both of which are linked to cardiovascular and respiratory harm. Because VOCs are emitted by many different kinds of sources, from gasoline stations and diesel trucks to paint shops, refineries, and chemical storage, the air in an industrial-adjacent neighborhood is a blended mixture in which no single concentration measurement can reveal responsibility. Source apportionment addresses this problem by using the relative pattern of many co-measured compounds as a diagnostic signature of each emission type.

The THRIVEair campaign grew out of longstanding community concern about air quality in neighborhoods close to Philadelphia’s industrial corridor. Fenceline communities, a term used for residential areas directly bordering large industrial operations, often experience elevated and highly variable pollutant concentrations depending on wind direction, facility operations, and time of day. Residents in such areas have historically lacked the dense, locally relevant monitoring data needed to demonstrate which sources dominate their exposure, a gap that can leave environmental agency decisions based on sparse regional averages rather than block-by-block reality. The study’s authors positioned THRIVEair as an effort to close that gap with sustained, neighborhood-scale measurement.

Methodologically, the research relied on time-resolved measurements of a wide suite of VOC species collected over an extended monitoring period at locations within the fenceline community. Analytical instruments captured compounds characteristic of different emission categories: aromatic hydrocarbons such as benzene, toluene, ethylbenzene, and xylenes, which trace gasoline combustion and solvent use; light alkanes and alkenes associated with natural gas, petrochemical operations, and vehicle exhaust; and chlorinated species that often indicate industrial solvent release or historical contamination. High-frequency sampling allowed the researchers to resolve short-term plumes and diurnal cycles that would be invisible to 24-hour integrated canister sampling alone.

The core of the analysis was receptor-based source apportionment, most commonly implemented through positive matrix factorization, or PMF, a statistical technique that takes the time series of many measured species and decomposes it into a small number of factors, each representing a distinct source profile with its own chemical fingerprint and temporal behavior. Rather than requiring an emissions inventory in advance, PMF lets the data themselves reveal how many source types are present and how much each contributes to the measured concentrations at the receptor location. The stability and interpretability of the resolved factors depend on the number and quality of the measured species, the frequency of sampling, and careful uncertainty estimation, all of which the study addressed in its design.

Interpreting the resolved factors typically involves cross-checking their chemical profiles and temporal patterns against known local activity. A traffic factor, for example, tends to peak during morning and evening rush hours and to be enriched in benzene and lighter aromatics, while an industrial or petrochemical factor may show a different compound ratio pattern and correlate with winds arriving from the direction of specific facilities. Meteorological data, including wind speed and direction, are usually incorporated to test whether factor contributions align with plausible source locations. This triangulation of chemistry, timing, and wind direction is what transforms a statistical factor into a defensible attribution of pollution to a source category.

The study’s findings carry significance both locally and methodologically. Locally, quantifying the share of VOC exposure attributable to industrial sources versus mobile sources versus regional background gives community members, public health officials, and regulators a factual basis for prioritizing interventions. If a substantial fraction of carcinogenic VOC exposure traces to a small number of industrial source categories, then targeted emission controls, fenceline monitoring requirements, or operational changes at specific facilities become evidence-backed priorities. Conversely, if traffic dominates, the intervention levers shift toward transportation policy, fleet electrification, and street-level exposure management. The apportionment results therefore function as a decision map rather than a mere description.

Methodologically, the work adds to a growing body of literature demonstrating that community-scale monitoring paired with receptor modeling can resolve source contributions that regional networks average away. Traditional regulatory monitoring in the United States relies on a limited number of sites, often sited to represent broad urban backgrounds, which systematically underestimates the exposure of people living immediately adjacent to emission sources. Studies like THRIVEair illustrate how denser, community-led or community-partnered measurement can capture the plume dynamics, wind-driven variability, and compound-specific signatures that define fenceline exposure. This approach aligns with a broader movement in environmental health toward citizen-science-informed monitoring and environmental justice screening tools that identify communities bearing disproportionate pollution burdens.

The environmental justice dimension is central to the study’s framing. Communities of color and lower-income neighborhoods in many American cities are disproportionately located near industrial zoning, freight corridors, and port facilities, and Philadelphia is no exception. Documenting elevated or source-attributable VOC concentrations in such neighborhoods provides quantitative support for the lived experience of residents who have long reported odors, health symptoms, and industrial incidents that went unmeasured by official networks. Source apportionment strengthens this documentation because it links measured exposure to identifiable emission categories, making it harder for the contribution of specific activities to be dismissed as background noise.

For the broader scientific community, the THRIVEair results contribute to the ongoing refinement of VOC source profiles in a modern urban environment. Emission compositions change over time as vehicle fleets evolve, fuel formulations shift, natural gas infrastructure ages, and industrial processes modernize, meaning that source profiles derived from studies conducted a decade or more ago may no longer represent current conditions. Fresh, locally derived apportionment results help update the emission inventories and chemical transport model inputs that underpin air quality forecasting, health risk assessment, and regulatory modeling. They also provide benchmarks against which future measurements can be compared to evaluate whether interventions are actually reducing the targeted source contributions.

The study also highlights practical considerations for communities elsewhere that want to understand their own air quality. Effective fenceline apportionment requires sustained funding for instruments and analysis, careful site selection to capture both source-influenced and background-influenced air, quality assurance protocols that withstand scientific and legal scrutiny, and genuine partnership with residents so that monitoring reflects local priorities and knowledge. The THRIVEair model, in which measurement campaigns are designed around community questions and results are translated into actionable findings, offers a template that other fenceline communities near refineries, chemical plants, ports, and freight hubs could adapt.

Ultimately, the research transforms an abstract complaint about industrial air into a quantified, compound-by-compound accounting of who contributes what to the air a fenceline community breathes. By resolving the mixture of volatile organic compounds into its constituent sources, the THRIVEair study gives Philadelphia residents, health officials, and regulators a shared factual foundation, and it demonstrates that modern exposure science can deliver the neighborhood-scale evidence that environmental justice demands. As cities nationwide grapple with legacy industrial zoning and expanding freight activity, the study stands as an example of how targeted monitoring and rigorous source apportionment can turn ambient air data into leverage for public health protection.

Subject of Research: Source apportionment of volatile organic compounds in a Philadelphia fenceline community using the THRIVEair monitoring campaign

Article Title: Source apportionment of volatile organic compounds in a Philadelphia fenceline community: results from THRIVEair

Article References: Frueh, L., Moore, K., Tiegs, G., Wahl, K., Johnston, L., Clougherty, J. E., Johnston, N. A. C., & Tripathy, S. (2026). Source apportionment of volatile organic compounds in a Philadelphia fenceline community: results from THRIVEair. Journal of Exposure Science & Environmental Epidemiology. https://doi.org/10.1038/s41370-026-00976-2

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00976-2

Keywords: volatile organic compounds, source apportionment, fenceline community, Philadelphia, air quality monitoring, environmental justice, positive matrix factorization, exposure science, industrial emissions, community health, THRIVEair, benzene

The technical foundation of the dispute lies in two biomarkers. Ethylene is a simple gaseous molecule that humans both produce internally and inhale from the environment, including from combustion sources and ripening fruit. Inside the body, a fraction of inhaled ethylene is converted by cytochrome P450 enzymes into ethylene oxide, a more reactive epoxide that can bind to hemoglobin and DNA. The specific biomarker used to track this chemistry is N-(2-hydroxyethyl)valine, abbreviated HEV, an adduct formed when ethylene oxide reacts with the N-terminal valine residue of hemoglobin proteins. Because red blood cells circulate for roughly four months, HEV provides an integrated record of ethylene oxide exposure over time. Lin and colleagues compiled a database of breath ethylene measurements and, using physiologically based pharmacokinetic modeling, sought to estimate how much endogenous ethylene oxide production contributes to total HEV burdens in the general population.

What Kirman and Bus highlight in their correspondence is a fundamental analytical problem embedded in that database. Breath ethylene concentrations reported across the literature are extraordinarily variable, and the variability appears to track with the measurement technology rather than with genuine differences between study populations. Studies employing laser-based photoacoustic spectrometry, a technique that detects gas absorption of laser light, reported mean ethylene concentrations of roughly 61 parts per billion with a standard deviation of 130 ppb, an enormous spread. By contrast, studies relying on gas chromatography reported a mean of approximately 20 ppb with a standard deviation of 16 ppb, far tighter and consistently lower. Even within the subset of studies that Lin and colleagues designated as high confidence, mean ethylene levels hovered around just 0.5 ppb, orders of magnitude below the values coming from the laser-based literature.

This is not a new concern, and Kirman and Bus invoke a striking historical precedent. More than two decades ago, Berkelmans and colleagues, working with online laser photoacoustic detection, observed that endogenous ethylene production rates derived from laser-based studies were significantly lower than published values based on gas chromatography, an inconsistency they attributed to fundamental differences between the two analytical approaches. When Berkelmans’s team attempted to fit a physiologically based pharmacokinetic model to their laser-derived data, they found they had to modify measured physiological and biochemical parameters to make the model work, indicating that the laser measurements were inconsistent with the well-established understanding of ethylene toxicokinetics built on gas chromatography. Kirman and Bus argue that this methodological fault line has not been resolved, and that Lin and colleagues’ database largely inherits the problem rather than correcting it.

The PBPK modeling itself is the second pillar of the critique. Physiologically based pharmacokinetic models are mathematical descriptions of how a chemical moves through the body, incorporating blood flow, tissue partitioning, metabolic rates, and ventilation. The model used by Lin and colleagues traces back to the foundational work of Filser and Klein, who developed a toxicokinetic model for inhaled ethylene and ethylene oxide across mouse, rat, and human species, and to earlier work by Csanády and colleagues, who modeled the formation of 2-hydroxyethyl adducts with hemoglobin and DNA from both exogenous and endogenous sources. Running the model with the breath ethylene data, Lin’s team concluded that endogenous production pathways account for less than 20 percent of total HEV in nonsmokers, leaving more than 80 percent unexplained. Kirman and Bus point out that this large unexplained fraction is itself a signal that something in the exposure reconstruction may be missing, whether it be analytical bias in breath measurements, unrecognized internal sources, or contributions from pathways not captured by the model.

Exogenous exposure, meaning ethylene and ethylene oxide inhaled from outside sources such as ambient and indoor air, is the other candidate explanation for the unaccounted adduct burden. Here, Kirman and Bus note that available air monitoring data, including large-scale studies such as Health Canada’s Windsor Exposure Assessment Study, indicate that environmental contributions to total ethylene oxide body burden are expected to be small for the general population. This conclusion aligns with their own prior publications, including a 2021 comprehensive review characterizing total ethylene oxide exposure from endogenous and exogenous pathways and a 2025 assessment of background exposures in the United States that questioned theoretical health risks for populations living near industrial sources. The implication is that the apparent gap between modeled endogenous production and measured HEV cannot simply be closed by invoking ambient air pollution, contrary to some popular narratives about ethylene oxide risk.

The broader context makes this technical disagreement consequential beyond the laboratory. Ethylene oxide is used industrially to sterilize roughly half of all medical devices in the United States, and the Environmental Protection Agency’s recent regulatory actions targeting sterilization facilities have relied on risk estimates derived from inhalation unit risk values. If a substantial fraction of the population’s hemoglobin adduct burden derives from endogenous biology rather than industrial emissions, then the margin between background internal exposure and levels associated with elevated cancer risk is narrower than many assume, and any risk assessment that fails to account for endogenous background risks mischaracterizing the true incremental danger of industrial emissions. Kirman and Bus have argued elsewhere that recognizing endogenous ethylene oxide formation is essential for a coherent risk management framework, since regulatory limits that ignore the body’s own production of the chemical cannot meaningfully protect public health in proportion to actual incremental exposure.

They also point to emerging molecular dosimetry work that helps interpret HEV data. Recent studies by Liu and colleagues on hemoglobin adduct formation in mice exposed to ethylene oxide, and Lin’s own companion work integrating PBPK modeling with tobacco biomarkers to interpret HEV levels in the U.S. population, demonstrate that smoking contributes substantially to measured adduct burdens, since tobacco smoke contains both ethylene and ethylene oxide directly. In nonsmokers, however, the origin of the remaining adduct burden remains contested. Classical biomonitoring studies from the 1990s and 2000s, including molecular dosimetry work by Walker, Fennell, Upton, and Swenberg in rodents exposed to ethylene oxide, established the dose-response framework that still underpins modern interpretation, and those studies consistently emphasized the importance of distinguishing background from incremental exposure when translating adduct measurements into cancer risk.

Neither the correspondence nor the original analysis settles the question of how much endogenous metabolism contributes to human ethylene oxide body burdens, but the exchange underscores a lesson that resonates across exposure science: the quality of a risk assessment is bounded by the quality of the exposure data fed into it. When two analytical technologies applied to the same biological matrix differ by more than an order of magnitude, as laser-based photoacoustic spectrometry and gas chromatography evidently do for breath ethylene, downstream models, no matter how sophisticated, inherit that uncertainty. Kirman and Bus contend that progress requires reconciling the methodological discrepancy, validating breath ethylene measurements against gas-chromatographic benchmarks, and ensuring that PBPK models are fit to data consistent with established toxicokinetics. Until that reconciliation occurs, estimates of how much ethylene oxide in the average person’s blood comes from industry versus biology will remain contested, and the regulatory debate over one of the world’s most widely used sterilants will continue to be fought on contested ground.

Subject of Research: Human exposure to ethylene and endogenous ethylene oxide assessed through breath biomarkers and pharmacokinetic modeling

Article Title: Regarding ethylene exposure and endogenous ethylene oxide levels in humans (Lin et al., 2025)

Article References: Regarding ethylene exposure and endogenous ethylene oxide levels in humans (Lin et al., 2025). (n.d.). https://doi.org/10.1038/s41370-026-00967-3

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00967-3

Keywords: ethylene, ethylene oxide, hemoglobin adducts, PBPK modeling, breath analysis, biomonitoring, exposure science, risk assessment, photoacoustic spectrometry, gas chromatography, environmental epidemiology, Regarding

The significance of this work lies in its comparative design. Most studies of metal exposure draw on a single population and a single set of biospecimens, which makes it difficult to know whether observed associations between metals and disease are robust or are artifacts of how exposure was measured. By aligning biomarker data across three cohorts that differ sharply in ancestry, geography, diet, and lifestyle, the researchers were able to probe how consistently metal concentrations appear in blood and urine, how the metals correlate with one another within individuals, and how demographic and behavioral characteristics shape the exposure profiles that epidemiologists rely on.

MASALA focuses on South Asian immigrants in the United States, a population that experiences elevated cardiovascular risk at lower body weights and through pathways that remain incompletely understood. Environmental exposures, including metals accumulated through diet, water, and occupational contact, have been proposed as one contributing factor. MESA-LA, part of the larger Multi-Ethnic Study of Atherosclerosis, brings together participants from multiple racial and ethnic groups in Los Angeles, offering a densely urban exposure environment shaped by traffic, industry, and aging infrastructure. The Strong Heart Family Study, meanwhile, is anchored in American Indian communities and benefits from family-based sampling, which allows investigators to account for shared genetic and household influences on measured biomarkers.

Metal biomarkers in epidemiology typically come from two matrices: whole blood and urine. Blood lead and blood cadmium reflect a combination of recent exposure and, in the case of lead, mobilization from long-term skeletal stores, making them useful integrative markers of cumulative internal dose. Urinary arsenic, cadmium, and other metals capture renal excretion of absorbed doses over recent days to years, depending on the element and its chemical form. The choice of matrix matters enormously. A metal that is well measured in urine may be poorly captured in blood, and vice versa, and the interpretation of any given concentration depends on speciation, timing of sample collection, and the physiological behavior of the element in question.

A central theme of the new analysis is the metal mixture itself. Environmental exposures rarely arrive one at a time. People are simultaneously exposed to dozens of metals through drinking water, rice and other grains, seafood, tobacco smoke, dust, and occupational settings, and these exposures can interact. Arsenic, cadmium, and lead, for example, have each been individually linked to cardiovascular disease, diabetes, and kidney dysfunction, but growing evidence suggests that their combined presence may produce risks that differ from the sum of their parts. Statistical approaches to mixtures, including methods that model correlated exposures jointly rather than one metal at a time, have therefore become a priority in environmental epidemiology, and their validity depends on having well-characterized, comparable biomarker data.

The three cohorts offer a natural laboratory for testing that comparability. Because MASALA, MESA-LA, and the Strong Heart Family Study each collected biospecimens under their own protocols, harmonization required careful attention to collection tubes, storage conditions, assay platforms, and quality control procedures. Differences in laboratory methods can introduce systematic bias that masquerades as true population differences, so cross-cohort analyses must document and, where possible, correct for such variation. The study’s comparative framework provides a template for how multi-cohort environmental research can be conducted rigorously, and its findings speak to both the promise and the practical challenges of pooling biomarker data across studies.

Population differences in metal biomarkers reflect more than differences in exposure. Diet composition plays a major role: rice consumption, which is relatively high among many South Asian communities, is a recognized pathway for inorganic arsenic intake, while seafood consumption drives methylmercury and contributes organic arsenic species that can confound urinary arsenic measurements if not separated analytically. Smoking is a dominant source of cadmium, so tobacco use patterns strongly influence cadmium distributions. Housing age and water systems affect lead exposure, and regional geology shapes background arsenic and uranium in drinking water. Sex, age, kidney function, and iron status further modify how metals are absorbed, distributed, and excreted, meaning that identical external exposures can yield different biomarker readings in different people.

These considerations matter because metal exposure is increasingly recognized as a modifiable cardiovascular risk factor. Large pooled analyses have associated low-level arsenic, cadmium, and lead exposure with hypertension, atherosclerosis, coronary heart disease, and cardiovascular mortality at concentrations once considered inconsequential. If biomarker measurements can be harmonized across diverse cohorts, investigators can test whether these associations replicate across ancestries and environments, estimate exposure–response relationships with greater precision, and identify subgroups bearing disproportionate burdens. That is precisely the kind of evidence needed to inform regulatory standards for drinking water, food, and consumer products, and to target screening or interventions toward the communities at highest risk.

The Strong Heart Family Study adds a further dimension: the ability to examine familial aggregation of metal biomarkers. Family-based designs can help distinguish shared household and environmental sources from genetic contributions to biomarker variation, and they permit exploration of how exposures in one generation may relate to health outcomes in the next. Metals cross the placenta, and early-life exposure has been linked to developmental and cardiometabolic outcomes, making intergenerational considerations central to the public health significance of metal mixtures. Including a family-based American Indian cohort alongside two urban cohorts therefore broadens the inferential reach of the analysis considerably.

For the broader environmental health community, the study underscores a practical message: biomarker-based exposure assessment is feasible and informative at scale, but it demands transparency about methods and humility about interpretation. Cross-cohort variation in metal concentrations should not be over-read as pure exposure difference when analytical and physiological factors are in play. At the same time, the consistency of measurable metal burdens across three demographically distinct American populations is itself a striking finding, a reminder that industrial-era contaminants have become a routine feature of human internal chemistry. As mixture methods mature and cohorts continue to accrue health outcomes, harmonized metal biomarker data of this kind will underpin the next generation of research linking environmental exposures to chronic disease, and could ultimately help shift prevention efforts upstream, toward the sources of exposure themselves.

Subject of Research: Comparative assessment of metal and metal mixture biomarkers across three U.S. population cohorts

Article Title: Metal and metal mixture biomarkers across three U.S. cohorts: MASALA, MESA-LA, and Strong Heart Family Study

Article References: Schilling, K., Martinez-Morata, I., Anderson, W. A., Basu, A., Izuchukwu, C., Collado, W., Navas-Acien, A., & Kanaya, A. M. (2026). Metal and metal mixture biomarkers across three U.S. cohorts: MASALA, MESA-LA, and Strong Heart Family Study. Journal of Exposure Science & Environmental Epidemiology. https://doi.org/10.1038/s41370-026-00954-8

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00954-8

Keywords: metal biomarkers, metal mixtures, MASALA, MESA-LA, Strong Heart Family Study, environmental epidemiology, arsenic, cadmium, lead exposure, cardiovascular risk, exposure science, cohort studies